Name: Hypofractionation Radiotherapy in Post Mastectomy breast cancer (en Inglés)
Price: 70950.00 CLP
Availability: InStock
Author: Rotich, Peter
ISBN: 9786139872886

$portada Hypofractionation Radiotherapy in Post Mastectomy breast cancer (en Inglés)$

Formato

Libro Físico

Autor

Peter Rotich

Editorial

LAP Lambert Academic Publishing

Idioma

Inglés

N° páginas

Encuadernación

Tapa Blanda

Dimensiones

22.9 x 15.2 x 0.4 cm

Peso

0.11 kg.

ISBN13

9786139872886

Categorías

Medicina clínica e interna

Hypofractionation Radiotherapy in Post Mastectomy breast cancer (en Inglés)

Peter Rotich (Autor) · LAP Lambert Academic Publishing · Tapa Blanda

Libro Nuevo

$ 70.950

$ 98.540

Ahorras: $ 27.590

28% descuento

Envío normal

Origen: Estados Unidos (Costos de importación incluídos en el precio)

Se enviará desde nuestra bodega entre el Jueves 18 de Julio y el Jueves 25 de Julio.

Lo recibirás en cualquier lugar de Chile entre 1 y 3 días hábiles luego del envío.

Reseña del libro "Hypofractionation Radiotherapy in Post Mastectomy breast cancer (en Inglés)"

Radiation-induced toxicity is still the main problem with patients undergoing breast or chest wall radiotherapy. Hypofractionated radiotherapy treatment utilises high dose per fraction compared to conventional, as such, concerns of increased toxicity exists. However, some studies have shown similarity in toxicity outcomes between hypofractionated treatment using 40 - 42.5 Gy in 15 - 16 fractions and conventional fractionation of 50 Gy in 2 Gy fractionation in patients who have undergone either breast conservation surgery or lumpectomy in early breast cancer. More high quality comparative hypofractionated radiotherapy studies on the whole breast and breast conservation surgery caseshave been reported compared to hypofractionated studies in postmastectomy patients requiring chest wall radiotherapy.Though, few large scales randomised controlled studies have been reportedsuchas START B trial which had 133 post-mastectomy patients outof 1079 patients sampled.Thus, this study sought to explore further the toxicity outcomes in hypofractionated treatments in early breast cancer postmastectomy in comparison with conventional fractionation.